C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation

被引：0
|
作者：
Mingkun Chen
Yunlin Ye
Baojia Zou
Suping Guo
Fangjian Zhou
Keshi Lu
Jianye Liu
Zhenzhou Xu
Hui Han
Zhuowei Liu
Yonghong Li
Kai Yao
Cundong Liu
Zike Qin
机构：
[1] State Key Laboratory of Oncology in South China,Department of Urology, Cancer Center
[2] Sun Yat-sen University,Department of Urology
[3] The Third Affiliated Hospital of Southern Medical University,Department of Urology
[4] Shenzhen Children’s Hospital,Department of Urology
[5] The Third Xiangya Hospital of Central South University,Department of Urology
[6] Hunan Cancer Hospital,Department of Radiotherapy, Cancer Center
[7] Sun Yat-sen University,undefined
来源：
Journal of Translational Medicine | / 14卷
关键词：
Bladder cancer; C14orf166; Prognosis; Cell proliferation; G1/S phase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation
    Chen, Mingkun
    Ye, Yunlin
    Zou, Baojia
    Guo, Suping
    Zhou, Fangjian
    Lu, Keshi
    Liu, Jianye
    Xu, Zhenzhou
    Han, Hui
    Liu, Zhuowei
    Li, Yonghong
    Yao, Kai
    Liu, Cundong
    Qin, Zike
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [2] C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence
    Chen, Jianxu
    Chen, Jiandi
    Gong, Yihang
    Zou, Baojia
    Liu, Xialei
    Ding, Lei
    Huang, Jiaxing
    Zhang, Baimeng
    Li, Jian
    JOURNAL OF INVESTIGATIVE SURGERY, 2020, 33 (10) : 914 - 923
  • [3] C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer
    Cheang, Tuck-yun
    Zhou, Hong-yan
    Chen, Wei
    Zhang, Bing
    Liu, Liangshuai
    Yang, Jianyong
    Wang, Shenming
    Li, Heping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14 : 11
  • [4] Role of C14orf166 in viral infection and RNA metabolism and its relationship with cancer
    Chen, Qiangxing
    Li, Rong
    MOLECULAR MEDICINE REPORTS, 2021, 23 (06)
  • [5] C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer
    Tuck-yun Cheang
    Hong-yan Zhou
    Wei Chen
    Bing Zhang
    Liangshuai Liu
    Jianyong Yang
    Shenming Wang
    Heping Li
    Journal of Translational Medicine, 14
  • [6] CALN1 hypomethylation as a biomarker for high-risk bladder cancer
    Kimiaki Takagi
    Azumi Naruse
    Kazutoshi Akita
    Yuka Muramatsu-Maekawa
    Kota Kawase
    Takuya Koie
    Masanobu Horie
    Arizumi Kikuchi
    BMC Urology, 22
  • [7] CALN1 hypomethylation as a biomarker for high-risk bladder cancer
    Takagi, Kimiaki
    Naruse, Azumi
    Akita, Kazutoshi
    Muramatsu-Maekawa, Yuka
    Kawase, Kota
    Koie, Takuya
    Horie, Masanobu
    Kikuchi, Arizumi
    BMC UROLOGY, 2022, 22 (01)
  • [8] Monitoring high-risk bladder cancer
    Schwentner, Christian
    Stenzl, Arnulf
    Gakis, Georgios
    CURRENT OPINION IN UROLOGY, 2012, 22 (05) : 421 - 426
  • [9] Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma
    Zhou, Yan-Wu
    Li, Rong
    Duan, Chao-Jun
    Gao, Yang
    Cheng, Yuan-Da
    He, Zhi-Wei
    Zeng, Jun-Xian
    Zhang, Chun-Fang
    MOLECULAR MEDICINE REPORTS, 2017, 15 (02) : 605 - 612
  • [10] High-Risk Nonmuscle Invasive Bladder Cancer
    Orsola, Anna
    Palou, Joan
    Solsona, Eduardo
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (02) : 227 - +
12345